HealthEquity Total Non-Operating Income/Expense 2014-2025 | HQY
HealthEquity annual/quarterly total non-operating income/expense history and growth rate from 2014 to 2025. Total non-operating income/expense can be defined as the sum of all non-operating expenses for the given industry.
- HealthEquity total non-operating income/expense for the quarter ending January 31, 2025 was $-0.012B, a 32.92% increase year-over-year.
- HealthEquity total non-operating income/expense for the twelve months ending January 31, 2025 was $-0.046B, a 8.54% increase year-over-year.
- HealthEquity annual total non-operating income/expense for 2025 was $-0.046B, a 8.54% increase from 2024.
- HealthEquity annual total non-operating income/expense for 2024 was $-0.043B, a 9.53% decline from 2023.
- HealthEquity annual total non-operating income/expense for 2023 was $-0.047B, a 10.94% increase from 2022.
| HealthEquity Annual Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025 | $-46 |
| 2024 | $-43 |
| 2023 | $-47 |
| 2022 | $-43 |
| 2021 | $-30 |
| 2020 | $-34 |
| 2019 | $-2 |
| 2018 | $-2 |
| 2017 | $-1 |
| 2016 | $-1 |
| 2015 | $-1 |
| 2014 | $-6 |
| 2013 | $-1 |
| HealthEquity Quarterly Total Non-Operating Income/Expense (Millions of US $) |
|
|---|---|
| 2025-01-31 | $-12 |
| 2024-10-31 | $-13 |
| 2024-07-31 | $-12 |
| 2024-04-30 | $-8 |
| 2024-01-31 | $-9 |
| 2023-10-31 | $-10 |
| 2023-07-31 | $-11 |
| 2023-04-30 | $-13 |
| 2023-01-31 | $-13 |
| 2022-10-31 | $-12 |
| 2022-07-31 | $-11 |
| 2022-04-30 | $-11 |
| 2022-01-31 | $-17 |
| 2021-10-31 | $-9 |
| 2021-07-31 | $-7 |
| 2021-04-30 | $-10 |
| 2021-01-31 | $0 |
| 2020-10-31 | $-7 |
| 2020-07-31 | $-10 |
| 2020-04-30 | $-13 |
| 2020-01-31 | $-15 |
| 2019-10-31 | $-41 |
| 2019-07-31 | $-1 |
| 2019-04-30 | $24 |
| 2019-01-31 | $0 |
| 2018-10-31 | $-2 |
| 2018-07-31 | $0 |
| 2018-04-30 | $0 |
| 2018-01-31 | $-2 |
| 2017-10-31 | $0 |
| 2017-07-31 | $0 |
| 2017-04-30 | $0 |
| 2017-01-31 | $0 |
| 2016-10-31 | $0 |
| 2016-07-31 | $0 |
| 2016-04-30 | $-1 |
| 2016-01-31 | $0 |
| 2015-10-31 | $0 |
| 2015-07-31 | $-1 |
| 2015-04-30 | $0 |
| 2015-01-31 | $0 |
| 2014-10-31 | $0 |
| 2014-07-31 | $0 |
| 2014-04-30 | $-1 |
| 2014-01-31 | |
| 2013-10-31 | $0 |
| 2013-07-31 | $0 |
| 2013-01-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $7.311B | $1.200B |
| HealthEquity provides integrated solutions for health-care account management, health reimbursement arrangement and flexible spending accounts for health plans, insurance companies and third-party administrators in the United States. HealthEquity's flagship health savings account or HSA is a financial account through which consumers spend and save for the long term for healthcare on a tax-advantaged basis. This has provided the company with a competitive edge in the MedTech industry. Other than HSAs, the company offers Healthcare saving and spending platform, Investment platform and advisory services and Reimbursement arrangements. In addition, HealthEquity offers health reimbursement and flexible spending arrangements solutions; Employee Retirement Income Security Act's plan administration and investment services. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $133.529B | 24.94 |
| Elevance Health (ELV) | United States | $96.108B | 12.88 |
| CVS Health (CVS) | United States | $84.839B | 12.41 |
| Cencora (COR) | United States | $55.604B | 20.18 |
| DiDi Global (DIDIY) | China | $20.317B | 29.86 |
| Natera (NTRA) | United States | $20.018B | 0.00 |
| BioMerieux (BMXMF) | France | $15.594B | 0.00 |
| Solventum (SOLV) | United States | $11.463B | 10.69 |
| ICON (ICLR) | Ireland | $11.251B | 10.22 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.063B | 0.00 |
| Revvity (RVTY) | United States | $11.032B | 18.74 |
| CochLear (CHEOY) | Australia | $10.876B | 0.00 |
| Avantor (AVTR) | United States | $10.289B | 15.10 |
| Doximity (DOCS) | United States | $9.934B | 51.66 |
| Viatris (VTRS) | United States | $9.024B | 2.85 |
| Medpace Holdings (MEDP) | United States | $8.956B | 23.46 |
| Sonic Healthcare (SKHHY) | Australia | $7.706B | 0.00 |
| Charles River Laboratories (CRL) | United States | $5.209B | 10.28 |
| Amplifon S.p.A (AMFPF) | Italy | $4.285B | 22.62 |
| Bausch + Lomb (BLCO) | Canada | $4.262B | 19.45 |
| Alignment Healthcare (ALHC) | United States | $3.499B | 0.00 |
| Sotera Health (SHC) | United States | $2.975B | 17.18 |
| BrightSpring Health Services (BTSG) | United States | $2.905B | 30.18 |
| Organon (OGN) | United States | $2.868B | 2.92 |
| Surgery Partners (SGRY) | United States | $2.708B | 31.21 |
| GeneDx Holdings (WGS) | United States | $2.680B | 318.23 |
| Concentras Parent (CON) | United States | $2.613B | 13.59 |
| Progyny (PGNY) | United States | $1.837B | 40.45 |
| Ardent Health Partners (ARDT) | United States | $1.786B | 0.00 |
| Premier (PINC) | United States | $1.765B | 11.30 |
| GoodRx Holdings (GDRX) | United States | $1.720B | 37.38 |
| Agilon Health (AGL) | United States | $1.649B | 0.00 |
| PACS (PACS) | United States | $1.411B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.197B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.100B | 9.22 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.035B | 0.00 |
| CareDx (CDNA) | United States | $0.977B | 16.62 |
| Establishment Labs Holdings (ESTA) | $0.907B | 0.00 | |
| Nutex Health (NUTX) | United States | $0.824B | 16.14 |
| AMN Healthcare Services Inc (AMN) | United States | $0.706B | 5.59 |
| Embecta (EMBC) | United States | $0.659B | 4.52 |
| Auna S.A (AUNA) | Luxembourg | $0.515B | 13.65 |
| QDM (QDMI) | Hong Kong, SAR China | $0.496B | 0.00 |
| SBC Medicals (SBC) | United States | $0.417B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.405B | 0.00 |
| Enhabit (EHAB) | United States | $0.388B | 36.57 |
| InnovAge Holding (INNV) | United States | $0.372B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.290B | 0.00 |
| LifeMD (LFMD) | United States | $0.242B | 0.00 |
| DocGo (DCGO) | United States | $0.216B | 8.83 |
| Performant Healthcare (PHLT) | United States | $0.195B | 0.00 |
| Oncology Institute (TOI) | United States | $0.163B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.128B | 0.00 |
| Beauty Health (SKIN) | United States | $0.106B | 0.00 |
| So-Young (SY) | China | $0.084B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.082B | 0.00 |
| OncoCyte (OCX) | United States | $0.081B | 0.00 |
| Biodesix (BDSX) | United States | $0.080B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.065B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.062B | 0.00 |
| NeueHealth (NEUE) | United States | $0.053B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.018B | 0.00 |
| ModivCare (MODV) | United States | $0.014B | 4.93 |
| Co-Diagnostics (CODX) | United States | $0.012B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| KindlyMD (KDLY) | United States | $0.011B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| Aclarion (ACON) | United States | $0.005B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |